Iron, the substantia nigra and related neurological disorders.
about
Mitochondrial ferritin in the substantia nigra in restless legs syndromeParkinson's Disease: The Mitochondria-Iron LinkIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesThe perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effectsAge-dependent retinal iron accumulation and degeneration in hepcidin knockout miceBmp6 regulates retinal iron homeostasis and has altered expression in age-related macular degenerationMelanin-based coatings as lead-binding agentsDifferent susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1Possible association between vitamin D deficiency and restless legs syndrome.Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease.The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosisNeurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310Aconitase causes iron toxicity in Drosophila pink1 mutantsUsing high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.Inhibition of Sirtuin 2 exerts neuroprotection in aging rats with increased neonatal iron intakeA multicontrast approach for comprehensive imaging of substantia nigra.Systems genetic analysis of the effects of iron deficiency in mouse brain.Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review.Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal, Autonomic, and Motor SystemsDisrupted iron homeostasis causes dopaminergic neurodegeneration in mice.Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicityHuman L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome.Time- and cell-type specific changes in iron, ferritin, and transferrin in the gerbil hippocampal CA1 region after transient forebrain ischemiaIdentification of a fluorescent general anesthetic, 1-aminoanthracene.Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's diseaseIron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice.Systems genetics analysis of iron regulation in the brain.Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders.Mapping brain metals to evaluate therapies for neurodegenerative disease.Iron chelation and neuroprotection in neurodegenerative diseases.Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.HFE gene variants affect iron in the brain.Iron toxicity in neurodegeneration.Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration.Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.Welding-related brain and functional changes in welders with chronic and low-level exposure.Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.
P2860
Q24634189-0FF89F72-3540-40CF-A38C-C039BD9B5BA3Q26746899-757AEB94-6FBD-463E-A89C-DB5E659C793AQ28388335-28E9AD5E-8CF5-4D21-8DDD-2F72EAAC76C5Q28396222-0916CE3F-9E68-4679-B849-70280B665087Q28506439-78DE3FA4-AAAF-4706-AD73-627CB06B02E6Q28512223-3EC99C18-CAED-44BA-B362-91F3D03F3EC0Q28729995-AD255221-E255-4107-B2D9-B9068263CB42Q33646741-86AE0A1C-4547-4857-9BB5-CF6B0D8952FEQ33689751-E35D4D15-02CE-45ED-BC1C-DD65F02208E6Q33776138-A0867EB4-A4FA-4123-86DA-DF7C291F1B7DQ33938412-9D925C84-81BA-4AD0-A2E6-BD472B90E4A1Q34212422-D17CB8D0-FC92-4FC7-9B40-DEF5AA6E8E17Q34281402-9D64E267-0381-495E-96F8-E65F8749EC5EQ34292783-E874211C-BA8C-42EE-A37F-5B09915A2794Q34699834-A4B7B47F-9F79-4829-9C27-C6D6EDAA960BQ34792120-B073E4DF-F79A-40B0-A31A-DA014170BB31Q34798799-180E0994-2D64-464F-8948-2ECA52728EC0Q35555926-46BC1708-0F77-497A-9B59-E12FF9B6D70AQ36189556-7C6E9C62-B05E-43C8-8B11-6C8BDF8ED76BQ36351447-8546B4C4-26FC-4594-A4AF-69DA8D7D897FQ36385931-2B718AF2-3114-4948-9514-E82140E88A3EQ36770487-B606A108-674A-434D-A4D6-AFA5C68D086AQ37013755-61E77E74-4482-45FB-A534-517179603A64Q37125764-77EF4B82-2678-410F-9CEB-F04D209E7DA8Q37129758-F8D39F80-963C-40E0-B010-1CA5A678DC05Q37167655-AFF6F57B-7702-4A44-9846-06F09E2FE6EEQ37186193-3A9BF2FD-BACA-4DBD-A3A2-08F902B58FE7Q37227930-0F5CA923-D185-411E-8A41-84E04C6F365CQ37343285-16F51C07-0B9E-4EDD-87B7-102A44ECD9FDQ37671088-4FB5CACF-1D9D-40FC-9AFF-055ECBB6628BQ37725605-D6A1D535-425A-4B51-ACEE-EDA741828AD5Q37765635-7637A8F2-558A-4AB8-8698-00CF53005226Q37821331-D72ABBC6-AEA8-45D2-894D-58DF4B579A33Q37824440-F2BE4590-B854-4C63-8BBD-3EF3A2BBFBD8Q37846398-DBC685A9-CFCD-49A8-A6A7-E451107E27B1Q37982648-6F9A5D47-16ED-4E41-BA0C-3E824989602DQ38239577-10770E60-4CAC-4741-B72D-5C040BBC042DQ38627193-311F3A5F-82A2-4F49-853A-0070686F52ACQ38666930-AF30B4AB-90A6-4AE4-B575-0131E3CA10CBQ39075112-CF5D2508-34CE-4B60-9911-59A7CDA0EA04
P2860
Iron, the substantia nigra and related neurological disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Iron, the substantia nigra and related neurological disorders.
@en
Iron, the substantia nigra and related neurological disorders.
@nl
type
label
Iron, the substantia nigra and related neurological disorders.
@en
Iron, the substantia nigra and related neurological disorders.
@nl
prefLabel
Iron, the substantia nigra and related neurological disorders.
@en
Iron, the substantia nigra and related neurological disorders.
@nl
P1476
Iron, the substantia nigra and related neurological disorders.
@en
P2093
Amanda M Snyder
James R Connor
P304
P356
10.1016/J.BBAGEN.2008.08.005
P4011
2013f20be2ec80f3983860765ac30a9fadac99e3
P407
P577
2008-08-20T00:00:00Z